Skip to content
HowShorted

Moleculin Biotech, Inc. short interest in 2025

In 2025, Moleculin Biotech, Inc.'s disclosed short interest ran from 3.31% of shares outstanding on 14 Mar 2025 to 7.43% on 28 Nov 2025, a change of +4.12 percentage points. The year's high was 28.77% on 31 Oct 2025 and its low 3.31% on 14 Mar 2025, averaging 8.85% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.06 days on 30 May 2025. Full history: Moleculin Biotech, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2025

Aggregate net short position time series for Moleculin Biotech, Inc. in 2025

2025 in figures

Start of year
3.31% (14 Mar 2025)
End of year
7.43% (28 Nov 2025)
Change
+4.12 pp
High
28.77% (31 Oct 2025)
Low
3.31% (14 Mar 2025)
Average
8.85%
Highest days to cover
3.06 (30 May 2025)
SEC filings marked
7

Every report in 2025

Moleculin Biotech, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
14 Mar 20253.31%1.00
31 Mar 20254.09%1.0010-K filed, results (8-K)
15 Apr 20253.32%1.62
30 Apr 20255.18%2.02
15 May 20257.01%2.1710-Q filed, results (8-K)
30 May 20254.31%3.06
15 Aug 202510.89%2.8110-Q filed, results (8-K)
29 Aug 20259.13%1.00
15 Sep 20257.75%1.00
30 Sep 20259.32%1.00
15 Oct 202512.94%1.76
31 Oct 202528.77%1.55
14 Nov 202510.39%1.2810-Q filed
28 Nov 20257.43%1.47

See also: Moleculin Biotech, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.